Ankit Mahadevia - 27 Aug 2024 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
Director
Signature
/s/ Sath Shukla, Attorney-in-Fact for Ankit Mahadevia
Issuer symbol
SPRO
Transactions as of
27 Aug 2024
Net transactions value
-$7,981
Form type
4
Filing time
29 Aug 2024, 18:43:37 UTC
Previous filing
30 May 2024
Next filing
05 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRO Common Stock Sale $7,981 -5,912 -0.77% $1.35 759,085 27 Aug 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on August 26, 2021.

Remarks:

Chairman of the Board of Directors